Finally, Sweat has met its Patch

Finally, Sweat has met its Patch

Finally, Sweat has met its Patch

Candesant Biomedical, Inc. is a medical device company that has recently launched The Brella® SweatControl Patch.

Introducing targeted alkali thermolysis (TAT), a topical therapy for excessive sweating.​

Introducing targeted alkali thermolysis (TAT), a topical therapy for excessive sweating.​

Imagine "No Sweat" in Just Minutes

Administered in a Health Care Provider's Office
Non-Invasive Topical Patch​
Applied to the Underarm​
Stays on for Approximately 3 Minutes​
Minimal Discomfort, No Downtime

Our Technology: Targeted Alkali Thermolysis (TAT)

Focused delivery of heat through TAT, designed to inactivate the sweat glands.

Interaction between alkali metals and water

Flexible, easy to use bi-layer patch

Desired outcome: reduced sweating

Excessive Sweaters Need More Solutions

Excessive sweating results in a severe quality of life impact with limited satisfaction of current treatment options

  • 84 Million Excessive Sweaters¹

    84M (about 1/3) of U.S. adults are bothered by their sweating and/or think they sweat too much under their arms.

  • 15.3 Million Hyperhidrosis Sufferers²

    15.3M (~5%) of the U.S. population suffers so much it's considered a disease state called hyperhidrosis.

Interested in learning more about what it means to sweat too much?

¹Strutton, et. al., “US Prevalence of Hyperhidrosis and Impact on Individuals with Axillary Hyperhidrosis: Results from a National Survey.” JAAD, August 2004, Volume 51, Number 2; Census Bureau, Population Division, 2015 Projections

²Doolittle, J., Walker, P., Mills, T. et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res 308, 743–749 (2016). https://doi.org/10.1007/s00403-016-1697-9

Scroll to Top

For Healthcare Providers, join our mailing list for updates:

*Mandatory Fields

By submitting your contact information, you consent to being contacted by Brella for updates about our product und
marketing purposes. You may unsubscribe from these communications at any time. For more information, see our
Privacy Policy.

For Patients, join our mailing list for updates:

*Mandatory Fields

By submitting your contact information, you consent to being contacted by Brella for updates about our product und
marketing purposes. You may unsubscribe from these communications at any time. For more information, see our
Privacy Policy.

For all inquiries, please complete the following:

*Mandatory Fields

By submitting your contact information, you consent to being contacted by Brella for updates about our product und
marketing purposes. You may unsubscribe from these communications at any time. For more information, see our
Privacy Policy.

Introducing…

Learn more about Brella SweatControl Patch, FDA cleared, for the treatment of primary axillary hyperhidrosis (excessive underarm sweat), forging a new path forward for healthcare providers and the patients they treat.

Please join our mailing list to receive information on Brella’s availability for your practice

Please join our mailing list to receive information on Brella and how it could help control your excessive underarm sweating